Log in to search using one of your social media accounts:

Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix(R) (vortioxetine) sNDA
Valby, Denmark and Osaka, Japan, 23 June 2017 -- (Healthcare Sales & Marketing Network) -- H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) today announced that after providing additional analysis, the U.S. Food and Drug Admini... Biopharmaceuticals, FDA Takeda Pharmaceutical, H. Lundbeck, Trintellix, vortioxetine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 23, 2017 Category: Pharmaceuticals Source Type: news

AbbVie Receives CHMP Positive Opinion for MAVIRET(TM) (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)
If approved, MAVIRET™ will provide a shorter, 8-week, pan-genotypic (GT1-6), once-daily option for the majority of people living with the hepatitis C virus (HCV)(1)* MAVIRET would also be an additional HCV treatment option for patients with specific tre... Biopharmaceuticals, Regulatory AbbVie, MAVIRET, glecaprevir, pibrentasvir, hepatitis C (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 23, 2017 Category: Pharmaceuticals Source Type: news

Eton Pharmaceuticals Names Sean Brynjelsen Chief Executive Officer and Director
Mr. Brynjelsen to lead development of Eton's proprietary sterile injectable branded product candidates CHICAGO, June 23, 2017 -- (Healthcare Sales & Marketing Network) -- Eton Pharmaceuticals, Inc., a development stage pharmaceutical company, today ann... Biopharmaceuticals, Personnel Eton Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 23, 2017 Category: Pharmaceuticals Source Type: news

EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for the First-Line Treatment of Advanced Renal Cell Carcinoma in Europe
HEMEL HEMPSTEAD, England, June 23, 2017 -- (Healthcare Sales & Marketing Network) -- EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced that the European Medicines Agency's Committ... Biopharmaceuticals, Oncology, Regulatory EUSA Pharma, FOTIVDA, tivozanib, renal cell carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 23, 2017 Category: Pharmaceuticals Source Type: news

Halyard Health Announces CEO Transition
Abernathy to Retire as CEO; Continue as Chairman Woody Elected as CEO; Member of the Board of Directors ALPHARETTA, Ga., June 23, 2017 -- (Healthcare Sales & Marketing Network) -- Halyard Health, Inc., today announced that Robert E. Abernathy will r... Devices, Personnel Halyard Health (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 23, 2017 Category: Pharmaceuticals Source Type: news

LEO Pharma Appoints Chris Posner to Lead US Business
BALLERUP, Denmark, June 23, 2017 -- (Healthcare Sales & Marketing Network) -- LEO Pharma today announced that it appointed Chris Posner Executive Vice President Region US and President & CEO, LEO Pharma, Inc. From July 15, 2017, he will be responsible for... Biopharmaceuticals, Dermatology, Personnel LEO Pharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 23, 2017 Category: Pharmaceuticals Source Type: news

Millar, Inc. Sells Inca(R) Pressure-Volume (PV) Loop System to the University of Colorado to Support LVAD Research
HOUSTON, June 22, 2017 -- (Healthcare Sales & Marketing Network) -- Millar, Inc. is pleased to announce that the University of Colorado Anschutz Medical Campus has purchased the CD Leycom® Inca® Pressure-Volume (PV) Loop System – sold in North Ame... Devices, Cardiology Millar, Pressure-Volume Loop, ventricular assist device, LVAD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2017 Category: Pharmaceuticals Source Type: news

DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM
VANCOUVER, British Columbia and MENLO PARK, Calif., June 22, 2017 -- (Healthcare Sales & Marketing Network) -- DelMar Pharmaceuticals (Nasdaq: DMPI) ("DelMar" and "the Company"), a biopharmaceutical company focused on the development o... Biopharmaceuticals, Oncology DelMar Pharmaceuticals, Glioblastoma Multiforme, dianhydrogalactitol (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2017 Category: Pharmaceuticals Source Type: news

DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR(R)
Top-Line Data on Track for Q4 2017 CUPERTINO, Calif., June 22, 2017 -- (Healthcare Sales & Marketing Network) -- DURECT Corporation (Nasdaq: DRRX) today announced that patient enrollment has been completed in PERSIST, the pivotal Phase 3 clinical trial... Biopharmaceuticals DURECT, POSIMIR, SABER, Bupivacaine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2017 Category: Pharmaceuticals Source Type: news

Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/300 mg, 7.5 mg/300 mg And 10 mg/300 mg
PHILADELPHIA, June 22, 2017 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydroc... Biopharmaceuticals, Generics, FDA Lannett, Hydrocodone, Acetaminophen, Vicodin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2017 Category: Pharmaceuticals Source Type: news

Biohaven Broadens Senior Leadership Team With Veteran Pharma Executives
NEW HAVEN, Conn., June 22, 2017 -- (Healthcare Sales & Marketing Network) -- (NYSE: BHVN) - Biohaven Pharmaceutical Holding Company Ltd. (Biohaven) and it's wholly owned subsidiary, Biohaven Pharmaceuticals, Inc., today announced recent key additions to ... Biopharmaceuticals, Neurology, Personnel Biohaven Pharmaceuticals (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 22, 2017 Category: Pharmaceuticals Source Type: news

Additive Orthopaedics Announces FDA Clearance of their Minimally-Invasive, Intramedullary 3D Printed Bunion Correction System for the Extremities Market
LITTLE SILVER, N.J., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- Additive Orthopaedics, LLC., an orthopaedic device company, today announced that is has received FDA 510(k) clearance for its 3D printed minimally-invasive, intramedullary Bun... Devices, Orthopaedic, FDA Additive Orthopaedics, Bunion Correction System, Bunion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2017 Category: Pharmaceuticals Source Type: news

Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President and CEO to Commercialize Proprietary Theralink(R) Tumor Biomarker Platform
Dr. Goix brings 20 years of successful healthcare commercialization experience Two posters were presented at ASCO June 3rd, 2017 for Theralink® Breast Cancer GAITHERSBURG, Maryland, June 21, 2017 -- (Healthcare Sales & Marketing Network) -- Avan... Diagnostics, Oncology, Personnel Avant Diagnostics, Theralink (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2017 Category: Pharmaceuticals Source Type: news

Optim LLC Releases Next Generation LED for ENTity(TM) Series Flexible Endoscopes
The company's pioneering ENTity series now available with enhanced, brighter, second generation LED illumination for improved performance STURBRIDGE, Mass., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- Optim LLC, a premier manufacturer of... Devices, Product Launch Optim LLC, flexible laryngoscope, laryngoscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2017 Category: Pharmaceuticals Source Type: news

Advanced Sterilization Products Receives FDA Clearance For World's First 30-Minute Biological Indicator For Low Temperature H202 Sterilization
Faster results enable hospitals to test every single cycle to confirm sterility IRVINE, Calif., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- Advanced Sterilization Products (ASP) today announced it has received FDA clearance for its 30-mi... Devices, FDA Advanced Sterilization Products, STERRAD VELOCITY, Biological Indicator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2017 Category: Pharmaceuticals Source Type: news

Cardiome Announces Licensing Agreement for XYDALBA(TM) (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel
VANCOUVER, June 21, 2017 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME / TSX:COM) today announced that its affiliate has signed an exclusive license and distribution agreement with Tzamal Medical Ltd. ("Tzamal")... Biopharmaceuticals, Licensing Cardiome Pharma, Tzamal Medical, XYDALBA, ABSSSI, dalbavancin (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2017 Category: Pharmaceuticals Source Type: news

410 Medical Receives Funding from Triangle Venture Alliance (TVA) - A Newly Formed Network Based on Angel Investors tied to Leading North Carolina Universities
410 Medical Marks First Ever Investment by Triangle Venture Alliance DURHAM, N.C., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- 410 Medical, Inc., a medical device company focused on developing innovative technologies for the resuscitatio... Devices, Venture Capital 410 Medical, LifeFlow (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2017 Category: Pharmaceuticals Source Type: news

EnteroMedics Announces vBloc Therapy to be Presented by Keynote Speaker at Major International Obesity Conference
ST. PAUL, Minn., June 21, 2017 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Scott Shikora, M... Devices EnteroMedics, vBloc , Neurometabolic Therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 21, 2017 Category: Pharmaceuticals Source Type: news

NCCN Guidelines Compliance for Chest CT Reduces False Positives and Decreases Health Care Spending in Breast Cancer, Study Finds
As published in JNCCN, a Siteman Cancer Center study uncovered potential to significantly improve NCCN Guidelines-concordant care in patients with early-stage breast cancer FORT WASHINGTON, Pa., June 20, 2017 -- (Healthcare Sales & Marketing Network) -... Devices, Oncology, Radiology NCCN, NCCN Guidelines, breast MRI, computed tomography (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2017 Category: Pharmaceuticals Source Type: news

ANI Pharmaceuticals Announces Launch of Diphenoxylate HCl and Atropine Sulfate Tablets
BAUDETTE, Minn., June 20, 2017 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Diphenoxylate HCl and Atropine Sulfate Tablets, 2.5mg/0.025mg. The annual U.S. market for... Biopharmaceuticals, Generics, Product Launch ANI Pharmaceuticals, Diphenoxylate, Atropine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2017 Category: Pharmaceuticals Source Type: news

Hologic Announces FDA Clearance of Aptima(R) Assay to Detect Herpes Simplex Virus 1 and 2
Aptima HSV 1 & 2 Assay Now Available Alongside Women's Health, Virology Menu on the Fully Automated Panther System MARLBOROUGH, Mass. , June 20, 2017 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (Nasdaq: HOLX) announced today that it has ... Diagnostics, FDA Hologic, Aptima, Herpes Simplex Virus, Panther (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2017 Category: Pharmaceuticals Source Type: news

IUCT Oncopole Advances Cancer Care in France with the New Accuray Radixact(TM) System
The French Cancer Institute is Building its Re-irradiation and Adaptive Radiotherapy Program Using the Latest Technology Developed by Accuray SUNNYVALE, Calif., June 20, 2017 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (NASDAQ: AR... Devices, Oncology Accuray, Radixact, Delivery System, IGRT, IMRT, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2017 Category: Pharmaceuticals Source Type: news

BD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
New Micro-Laparoscopic Instruments Offer Surgeons Less Invasive Option for Patients FRANKLIN LAKES, N.J., June 20, 2017 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology com... Devices, Surgery, FDA BD , Snowden-Pencer, laparoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2017 Category: Pharmaceuticals Source Type: news

Lannett Names Patrick G. LePore To Board of Directors
PHILADELPHIA, June 20, 2017 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that Patrick G. LePore has been appointed to the company's Board of Directors, effective July 1, 2017. The addition of LePore will ... Biopharmaceuticals, Generics, Personnel Lannett (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 20, 2017 Category: Pharmaceuticals Source Type: news

FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA(R) (denosumab) To Include Multiple Myeloma Patients
FDA Sets PDUFA Target Action Date of Feb. 3, 2018 THOUSAND OAKS, Calif., June 19, 2017 -- (Healthcare Sales & Marketing Network) -- Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted the XGEVA® (denos... Biopharmaceuticals, Oncology, FDA Amgen, XGEVA, denosumab, Multiple Myeloma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2017 Category: Pharmaceuticals Source Type: news

FDA Accepts Rigel's New Drug Application for TAVALISSE(TM) (fostamatinib disodium) for the Treatment of Chronic ITP
SOUTH SAN FRANCISCO, Calif., June 19, 2017 -- (Healthcare Sales & Marketing Network) -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the U.S. Food and Drug Administration (FDA) has filed its New Drug Application (NDA) for the use of TAVALISS... Biopharmaceuticals, FDA Rigel Pharmaceuticals, TAVALISSE, fostamatinib, thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2017 Category: Pharmaceuticals Source Type: news

Stryker announces definitive agreement to acquire NOVADAQ Technologies Inc.
Kalamazoo, Michigan - June 19, 2017--(Healthcare Sales & Marketing Network)-- Stryker Corporation (NYSE:SYK) announced today a definitive agreement to acquire NOVADAQ Technologies Inc. (NASDAQ:NVDQ; TSX:NDQ) for US$11.75 per share, or US$701 million with a... Devices, Mergers & Acquisitions Stryker, NOVADAQ Technologies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2017 Category: Pharmaceuticals Source Type: news

Next Generation Lumbar Fusion Devices by Meditech Spine Aims to Improve Surgical Outcomes, Receives FDA Clearance
ATLANTA, June 19, 2017 -- (Healthcare Sales & Marketing Network) -- Spine surgery offers a new lease on life for patients experiencing back pain and discomfort. With an estimated 450,000+ lumbar fusions performed each year in the United States, surgeons a... Devices, Neurosurgery, Orthopaedic, FDA Meditech Spine, Talos Lumbar Peek, Degenerative Disc Disease, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2017 Category: Pharmaceuticals Source Type: news

NCCN Guidelines For Neuroendocrine Tumors Include XERMELO In Combination With Somatostatin Analog Therapy As A Recommended Treatment Option For Patients With Carcinoid Syndrome Diarrhea
THE WOODLANDS, Texas, June 19, 2017 -- (Healthcare Sales & Marketing Network) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that XERMELO™ (telotristat ethyl) 250 mg has been included as a recommended treatment option in the latest Nation... Biopharmaceuticals, Oncology Lexicon Pharmaceuticals, NCCN, XERMELO, carcinoid syndrome diarrhea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2017 Category: Pharmaceuticals Source Type: news

Ocugen Makes Strategic Appointments to Management Team
Company Strengthens Board with Three Key Director Appointments MALVERN, Pa., June 19, 2017 -- (Healthcare Sales & Marketing Network) -- Ocugen, Inc., a biopharmaceutical company developing treatments for sight-threatening diseases, today announced key ... Biopharmaceuticals, Ophthalmology, Personnel Ocugen, oGVHD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2017 Category: Pharmaceuticals Source Type: news

Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference
PRINCETON, N.J., June 19, 2017 -- (Healthcare Sales & Marketing Network) -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where t... Biopharmaceuticals, Oncology Soligenix, dusquetide, oral mucositis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 19, 2017 Category: Pharmaceuticals Source Type: news

Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg
PHILADELPHIA, June 16, 2017 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Amanta... Biopharmaceuticals, Generics, FDA Lannett, Amantadine, Symmetrel, influenza (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2017 Category: Pharmaceuticals Source Type: news

EULAR 2017: Lilly's Taltz(R) (ixekizumab) Demonstrated No Progression or Minimal Progression of Radiographic Disease in Patients with Psoriatic Arthritis Through 52 Weeks
INDIANAPOLIS, June 16, 2017 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that the majority of patients with active psoriatic arthritis (PsA) treated with Taltz® (ixekizumab) exhibited either no progres... Biopharmaceuticals Eli Lilly, Taltz, ixekizumab, psoriatic arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2017 Category: Pharmaceuticals Source Type: news

New Safety and Long-Term Efficacy Data from Baricitinib Clinical Trials in Patients with Moderate-to-Severe Rheumatoid Arthritis Presented at EULAR 2017
Pooled analysis of eight clinical trials shows no difference in serious infection events compared to placebo Results from long-term extension of Phase 3 studies show treatment with baricitinib slows the progression of joint damage and controls disease a... Biopharmaceuticals Eli Lilly, Incyte , Olumiant, baricitinib, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2017 Category: Pharmaceuticals Source Type: news

Johnson and Johnson Announces Completion of Acquisition of Actelion
Transaction Expands Janssen Portfolio with Leading Differentiated In-Market Medicines and Promising Late-Stage Therapies NEW BRUNSWICK, N.J., June 16, 2017 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson (NYSE: JNJ) today announced the c... Biopharmaceuticals, Mergers & Acquisitions Johnson & Johnson, Actelion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 16, 2017 Category: Pharmaceuticals Source Type: news

Charles J. Casamento Appointed Chairman of Relmada Therapeutics Board of Directors
Globally recognized leader in drug development and commercialization assumes Board leadership as Relmada advances clinical development of drug candidates to treat CNS disorders NEW YORK, June 15, 2017 -- (Healthcare Sales & Marketing Network) -- Relmad... Biopharmaceuticals, Personnel Relmada Therapeutics, methadone, mepivacaine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2017 Category: Pharmaceuticals Source Type: news

OBP Medical Announces SURE-SCOPE Regulatory Approval in Australia
Innovative, single-use, one-piece laryngoscope with integrated LED light source reduces cost, improves efficiency, eliminates infection risk caused by reusable laryngoscope blades and handles LAWRENCE, Mass., June 15, 2017 -- (Healthcare Sales & Marketi... Devices, Regulatory, Product Launch OBP Medical, SURE-SCOPE, laryngoscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2017 Category: Pharmaceuticals Source Type: news

Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure(R) for Non-Invasive Body Contouring (Lipolysis) of Back, Inner and Outer Thighs
SculpSure Now Cleared to Treat Five Areas of the Body MARLBOROUGH, Mass., June 15, 2017 -- (Healthcare Sales & Marketing Network) -- Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted an expanded c... Devices, FDA Hologic, Cynosure, SculpSure, body contouring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2017 Category: Pharmaceuticals Source Type: news

Magstim Group, Inc. Appoints Lothar Krinke as New CEO
MORRISVILLE, N.C., June 15, 2017 -- (Healthcare Sales & Marketing Network) -- Magstim Group, Inc., the pioneer in trans-cranial magnetic stimulation and intraoperative nerve monitoring, today announced that it has appointed Lothar Krinke, Ph.D., as Chief ... Devices, Neurology, Personnel Magstim, Technomed, Transcranial Magnetic Stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 15, 2017 Category: Pharmaceuticals Source Type: news

Venus Medtech Acquires U.S. Company InterValve to Create a Systematic TAVR Treatment and Strengthen Global Expansion
HANGZHOU, China, June 14, 2017 -- (Healthcare Sales & Marketing Network) -- Venus Medtech announced on June 13, 2017 that it has purchased U.S. Company InterValve, the supplier of balloon aortic valvuloplasty products, and that the relevant delivery proce... Devices, Interventional, Cardiology, Mergers & Acquisitions Venus Medtech, InterValve, valvuloplasty, aortic valve, transcatheter, TAVR (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2017 Category: Pharmaceuticals Source Type: news

Arena Pharmaceuticals Appoints Jennifer Jarrett to Board of Directors
SAN DIEGO, June 14, 2017 -- (Healthcare Sales & Marketing Network) -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today announced the appointment of Jennifer Jarrett to the Company's Board of Directors. Ms. Jarrett has over 20 years of experience as a se... Biopharmaceuticals, Personnel Arena Pharmaceuticals, ralinepag, etrasimod (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2017 Category: Pharmaceuticals Source Type: news

Twist Bioscience Raises Additional $27 Million
Aggregate New Funding in 2017 Reaches $60 Million; Total of $191 Million Raised Since Inception Accelerates Growth into Drug Discovery, Supports Investment in DNA Data Storage SAN FRANCISCO, June 14, 2017 -- (Healthcare Sales & Marketing Network) --... Biopharmaceuticals, Diagnostics, Venture Capital Twist Bioscience (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2017 Category: Pharmaceuticals Source Type: news

Eiger Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA to its Board of Directors
Company Prepares to Advance Orphan Disease Pipeline PALO ALTO, Calif., June 14, 2017 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of therapies for rare dise... Biopharmaceuticals, Personnel Eiger BioPharmaceuticals, Hepatitis Delta Virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 14, 2017 Category: Pharmaceuticals Source Type: news

TECHLAB(R) Receives FDA 510(k) Clearance To Market E. HISTOLYTICA QUIK CHEK(TM) To Aid Clinicians In The Diagnosis Of Amebiasis Caused By The E. Histolytica Parasite
E. HISTOLYTICA QUIK CHEK™ and GIARDIA/CRYPTOSPORIDIUM QUIK CHEK™ Provide a definitive diagnosis in parasite screening BLACKSBURG, Va., June 13, 2017 -- (Healthcare Sales & Marketing Network) -- TECHLAB,® Inc., a leading developer and manufacturer o... Diagnostics, FDA TECHLAB, E. HISTOLYTICA QUIK CHEK, Amebiasis, E. Histolytica (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news

Vertera Spine Receives New CMS ICD-10 Code for Radiolucent Porous Interbody Fusion Devices
COHERE Cervical Interbody Fusion Device is the only product approved for use with the new code ATLANTA, June 13, 2017 -- (Healthcare Sales & Marketing Network) -- Vertera Spine, a developer of medical devices using advanced biomaterial technologies, to... Devices, Orthopaedic, Neurosurgery, Reimbursement Vertera Spine, Interbody Fusion Device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news

Regulus Promotes Mark Deeg, M.D. PhD to Chief Medical Officer
LA JOLLA, Calif., June 13, 2017 -- (Healthcare Sales & Marketing Network) -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced the promo... Biopharmaceuticals, Personnel Regulus Therapeutics, microRNA (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news

Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE(R) in Canada for Opioid Drug Dependence
PRINCETON, N.J. and MONTREAL, June 13, 2017 -- (Healthcare Sales & Marketing Network) -- Braeburn Pharmaceuticals, Inc. ("Braeburn") and Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical compan... Biopharmaceuticals, Drug Delivery, Regulatory Braeburn Pharmaceuticals, Knight Therapeutics, PROBUPHINE, buprenorphine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news

Audentes Therapeutics Appoints Jennifer Jarrett to Board of Directors
SAN FRANCISCO, June 13, 2017 -- (Healthcare Sales & Marketing Network) -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatenin... Biopharmaceuticals, Personnel Audentes Therapeutics, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news

SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D(TM) Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System(R)
The iFuse-3D Implant combines the patented triangular shape of the iFuse Implant™ with a proprietary 3D-printed porous trabecular surface and unique patented fenestrated design to promote bone ongrowth, ingrowth, through growth and intra-articular fusion ... Devices, Neurosurgery, Orthopaedic, Product Launch SI-BONE, iFuse-3D, 3D-printed titanium implant, SI joint, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news

Zimmer Biomet Holdings Announces Resolution of FDA Warning Letter Related to Its Zhejiang, China Manufacturing Facility
WARSAW, Ind., June 13, 2017 -- (Healthcare Sales & Marketing Network) -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the U.S. Food and Drug Administration (FDA) has notified the Com... Devices, Orthopaedic, FDA Zimmer Biomet Holdings (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 13, 2017 Category: Pharmaceuticals Source Type: news